taurine for MELAS
Selected indexed studies
- Diagnosis and Management of Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes Syndrome. (Biomolecules, 2024) [PMID:39766231]
- [Taurine for Mitochondrial Diseases]. (Brain Nerve, 2024) [PMID:39370837]
- Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial. (J Neurol Neurosurg Psychiatry, 2019) [PMID:29666206]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Diagnosis and Management of Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes Syndrome. (2024) pubmed
- [Taurine for Mitochondrial Diseases]. (2024) pubmed
- Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial. (2019) pubmed
- Clinical features, pathogenesis, and management of stroke-like episodes due to MELAS. (2021) pubmed
- Role of taurine in the pathologies of MELAS and MERRF. (2014) pubmed
- Taurine deficiency and MELAS are closely related syndromes. (2013) pubmed
- [Therapeutics for Mitochondrial Encephalomyopathy]. (2023) pubmed
- Effects and Mechanisms of Taurine as a Therapeutic Agent. (2018) pubmed
- Mitochondrial tRNA modifications: functions, diseases caused by their loss, and treatment strategies. (2025) pubmed
- Taurine rescues mitochondria-related metabolic impairments in the patient-derived induced pluripotent stem cells and epithelial-mesenchymal transition in the retinal pigment epithelium. (2021) pubmed